Cipla

Sensex Tumbles Over 400 Points, Nifty Settles Below 14,500

Business | Edited by Peter Noronha | Tuesday May 4, 2021

Tata Consumer Products dived nearly 5 per cent to top the loser's list on the BSE, while pharma stocks such as Cipla, Dr Reddy's and Divi's Lab lost 1-3 per cent each

Sensex At Day's Low, Sheds Over 400 Points; Pharma Drags

Business | Edited by Peter Noronha | Tuesday May 4, 2021

Tata Consumer Products has dived nearly 5 per cent to top loser's list on BSE; pharma stocks are also trading weak, with Cipla, Dr Reddy's and Sun Pharma losing 1-3 per cent each

Merck Taps 5 Indian Drugmakers To Expand Covid Drug Production

India News | Reuters | Tuesday April 27, 2021

Merck & Co Inc said on Tuesday it had partnered with five Indian generic drugmakers, including Cipla Ltd and Sun Pharmaceutical Industries Ltd, to expand production and access to its experimental COVID-19 drug.

Cipla Doubles Remdesivir Production In India For "Unprecedented" Demand

India News | Reuters | Tuesday April 13, 2021

India's Cipla Ltd has doubled production of COVID-19 medication remdesivir to help meet "unprecedented demand" as the country battles a massive second wave of infections, the drugmaker said on Tuesday.

Pharma Stocks Rally On High Demand For Medicines Amid Rising COVID Cases

Business | Edited by Nikita Prasad | Friday April 9, 2021

Pharmaceutical stocks today: On Friday, Cipla opened on the NSE at Rs 840.90, touching an intra day high of Rs 892.30 and an intra day low of Rs 836.65, in the session so far

Sensex, Nifty Have A Subdued Closing Amid Volatility

Business | Edited by Peter Noronha | Tuesday March 16, 2021

The broader markets outperformed the larger peers, with the BSE Midcap index and BSE Smallcap indices gaining around 0.30 per cent each

Sensex Gains Over 500 Points To Hit Fresh Record Highs, Nifty Nears 14,800

Business | Edited by Peter Noronha (with inputs from agencies) | Wednesday February 3, 2021

Pharma stocks were witnessing buying interest; Dr Reddy's zoomed 4 per cent to top the gainers list among BSE Sensex stocks, while Cipla and Sun Pharma gained 3 per cent and 2 per cent respectively

Volume Decline Muted Pharmaceutical Market Growth In November

Business | Edited by Nikita Prasad | Tuesday December 22, 2020

The pharmaceutical market reported 128.3 billion total sales in November 2020 and decline in volume can be attributed to the lower sales of the acute therapy products

Cipla Gains Nearly 5% On Settlement of US Patent Litigation

Business | Edited by Peter Noronha | Monday December 14, 2020

Cipla share price jumps 5%: The pharma major has announced settlement of its patent litigation with Celgene Corporation, a wholly-owned subsidiary of Bristol Myers Squibb, in the United States

Stocks to Watch Today: UPL, KEC International, Cipla, Burger King

Business | Edited by Peter Noronha | Monday December 14, 2020

UPL shares may be on investor's radar after the company denied reports of SEBI initiating a forensic audit regarding whistleblower complaint

Cambridge University Names Chemistry Department After Cipla's Yusuf Hamied

Education | Reported by Press Trust of India | Tuesday December 1, 2020

In recognition of his “generous benefaction”, the University of Cambridge announced on Tuesday that its chemistry department will be named after Indian pharmaceutical major Cipla's non-executive chairman Yusuf Hamied until 2050.

Indian Demand For COVID-19 Drug Remdesivir Rising Sharply: Cipla

India News | Reuters | Monday November 9, 2020

Demand for COVID-19 antiviral drug remdesivir is rising sharply in India, a top executive at drugmaker Cipla Ltd said on Monday, even as experts remain divided over its effectiveness.

Share Market Updates: Sensex Rises Over 250 Points, Nifty Firm Above 11,950 Amid Broad-Based Gains

Business | Edited by Sandeep Singh (with inputs from agencies) | Friday October 23, 2020

Share Market Updates: Top gainers in the Nifty basket of 50 shares at the time were Tata Steel, Cipla, Indian Oil, Bharti Airtel and ICICI Bank.

Sensex Closes 304 Points Higher, Nifty Reclaims 11,800 As Markets Extend Rally To Sixth Day

Business | Edited by Sandeep Singh (with inputs from agencies) | Thursday October 8, 2020

Wipro, Cipla, TCS, UltraTech Cement and Infosys, ending between 3.01 per cent and 7.34 per cent higher, were the top gainers in the 50-scrip benchmark index.

Dr Reddy's Soars To Record High After Drug Maker Settles Patent Litigation In US

Business | Edited by Sandeep Singh | Friday September 18, 2020

The Nifty Pharma index - which captures the performance of 10 drug makers in the country, including Dr Reddy's, Lupin, Cipla and Sun Pharma - jumped as much as 3.66 per cent.